Evert de Vries

3.4k total citations · 1 hit paper
55 papers, 2.8k citations indexed

About

Evert de Vries is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Evert de Vries has authored 55 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 23 papers in Immunology and 16 papers in Oncology. Recurrent topics in Evert de Vries's work include T-cell and B-cell Immunology (18 papers), Cell death mechanisms and regulation (14 papers) and Immune Cell Function and Interaction (14 papers). Evert de Vries is often cited by papers focused on T-cell and B-cell Immunology (18 papers), Cell death mechanisms and regulation (14 papers) and Immune Cell Function and Interaction (14 papers). Evert de Vries collaborates with scholars based in Netherlands, United States and United Kingdom. Evert de Vries's co-authors include Jannie Borst, Annemiek D. Tepper, Wim J. van Blitterswijk, Stephen W. G. Tait, Jacques J. M. van Dongen, Ilja Bontjer, Gaby Brouns, Lodewyk F.A. Wessels, Chiel Maas and Anton Berns and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Evert de Vries

53 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators

2017 504 citations Riccardo Mezzadra, Chong Sun et al. Nature profile →

Peers

Countries citing papers authored by Evert de Vries

Since Specialization

Citations

This map shows the geographic impact of Evert de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evert de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evert de Vries more than expected).

Fields of papers citing papers by Evert de Vries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evert de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evert de Vries. The network helps show where Evert de Vries may publish in the future.

Co-authorship network of co-authors of Evert de Vries

This figure shows the co-authorship network connecting the top 25 collaborators of Evert de Vries. A scholar is included among the top collaborators of Evert de Vries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evert de Vries. Evert de Vries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD27 costimulation supports metabolic fitness of CD4+ T cells by enhancing de novo nucleotide and protein synthesis 2025 ·The Journal of Immunology ·(unknown), (unknown), Ellen Schrama, (unknown), (unknown), Evert de Vries, Jacqueline D.H. Anholts, Celia R. Berkers, Jannie Borst, Esther A. Zaal, Sander de Kivit	1
2	N-terminal acetylation can stabilize proteins independent of their ubiquitination 2023 ·Scientific Reports ·Bert van de Kooij, Evert de Vries, Rogier W. Rooswinkel, George M. C. Janssen, (unknown), Peter A. van Veelen, Jannie Borst	5
3	Subcellular Localization of Antigen in Keratinocytes Dictates Delivery of CD4+ T-cell Help for the CTL Response upon Therapeutic DNA Vaccination into the Skin 2018 ·Cancer Immunology Research ·Nikolina Bąbała, (unknown), Evert de Vries, (unknown), Tomasz Ahrends, Matthew F. Krummel, Jannie Borst, Adriaan D. Bins	10
4	Hunter-prey correlation between migration routes of African buffaloes and early hominids: Evidence for the “Out of Africa” hypothesis 2017 ·Integrative Molecular Medicine ·Vincent van Ginneken, (unknown), Tim Wijgerde, Elwin Verheij, Evert de Vries, J. van der Greef	2
5	Giant Mealworm (Zophobas Morio) as a “Vehicle” to Transport Healthy Nutritional Ingredients from Seaweed (Ascophyllum Nodosum) towards Fish Cultured: Amino Acids 2017 ·Socio-Environmental Systems Modeling ·Marit A. J. Nederlof, Caroline Durif, M.C.J. Verdegem, G.H.R. Booms, Evert de Vries, V.J.T. van Ginneken	3
6	Identification of CMTM6 and CMTM4 as PD-L1 protein regulators breakdown → 2017 ·Nature ·Riccardo Mezzadra, Chong Sun, Lucas T. Jae, Raquel Gomez-Eerland, Evert de Vries, Wei Wu, Meike E. W. Logtenberg, Maarten Slagter, Elisa A. Rozeman, Ingrid Hofland, Annegien Broeks, Hugo M. Horlings, Lodewyk F.A. Wessels, Christian U. Blank, Yanling Xiao, Albert J. R. Heck, Jannie Borst, Thijn R. Brummelkamp, Ton N. Schumacher	504
7	A Suggested "Seaweed-Plantation Model" to Tackle the Looming Phosphorus Crises in the 21st Century at the Rhine/North-Sea System". 2016 ·Vincent van Ginneken, Evert de Vries, Tim Wijgerde	4
8	Towards a Seaweed Based Economy: The Global Ten Billion People Issue at the Midst of the 21st Century 2016 ·Vincent van Ginneken, Evert de Vries	6
9	TOWARDS A SEAWEED BASED ECONOMY 2015 ·Vincent van Ginneken, Evert de Vries	1
10	Ubiquitination by the Membrane-associated RING-CH-8 (MARCH-8) Ligase Controls Steady-state Cell Surface Expression of Tumor Necrosis Factor-related Apoptosis Inducing Ligand (TRAIL) Receptor 1* 2013 ·Journal of Biological Chemistry ·Bert van de Kooij, Inge Verbrugge, Evert de Vries, Merel Gijsen, Verónica Montserrat, Chiel Maas, Jacques Neefjes, Jannie Borst	74
11	The mitogen-activated protein kinase pathway can inhibit TRAIL-induced apoptosis by prohibiting association of truncated Bid with mitochondria 2006 ·Cell Death and Differentiation ·(unknown), Stephen W. G. Tait, Gema Robledo, Evert de Vries, Jannie Borst, Abelardo López‐Rivas	16
12	TRAIL Receptor and CD95 Signal to Mitochondria via FADD, Caspase-8/10, Bid, and Bax but Differentially Regulate Events Downstream from Truncated Bid 2002 ·Journal of Biological Chemistry ·(unknown), Evert de Vries, Stephen W. G. Tait, Ilja Bontjer, Jannie Borst	52
13	Common Regulation of Apoptosis Signaling Induced by CD95 and the DNA-damaging Stimuli Etoposide and γ-Radiation Downstream from Caspase-8 Activation 1999 ·Journal of Biological Chemistry ·(unknown), Annemiek D. Tepper, Evert de Vries, Wim J. van Blitterswijk, Jannie Borst	103
14	CD95 (Fas/APO-1) Induces Ceramide Formation and Apoptosis in the Absence of a Functional Acid Sphingomyelinase 1998 ·Journal of Biological Chemistry ·(unknown), Annemiek D. Tepper, Evert de Vries, Wim J. van Blitterswijk, Jannie Borst	94
15	Assembly and intracellular transport of the human B cell antigen receptor complex 1995 ·International Immunology ·Gaby Brouns, Evert de Vries, Jannie Borst	38
16	CD3 components at the surface of pro‐T cells can mediate pre‐T cell development in vivo 1994 ·European Journal of Immunology ·Heinz Jacobs, (unknown), (unknown), Evert de Vries, Jannie Borst, Anton Berns	144
17	The CD27 membrane receptor, a lymphocyte‐specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis 1992 ·European Journal of Immunology ·Wil A. M. Loenen, Evert de Vries, Loes A. Gravestein, Rogier Q. Hintzen, René A. W. van Lier, Jannie Borst	80
18	BMA031, a monoclonal antibody suited to identify the T-cell receptor αβ/CD3 complex on viable human T lymphocytes in normal and disease states 1990 ·Human Immunology ·Jannie Borst, Jacques J. M. van Dongen, Evert de Vries, W M Comans-Bitter, (unknown), Jaak M. Vossen, R. Kurrle	36
19	Non‐random expression of T cell receptor γ and δ variable gene segments in functional T lymphocyte clones from human peripheral blood 1989 ·European Journal of Immunology ·Jannie Borst, (unknown), Jacques J. M. van Dongen, Evert de Vries, W M Comans-Bitter, (unknown), Peter J. van den Elsen	74
20	Distinct molecular forms of human T cell receptor gamma/delta detected on viable T cells by a monoclonal antibody. 1988 ·The Journal of Experimental Medicine ·Jannie Borst, Jacques J. M. van Dongen, R. L. H. Bolhuis, Florian Peters, David A. Hafler, Evert de Vries, R J van de Griend	155

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact